fr
Published by

June 12 marked the release of the Final Report of the Advisory Council on the Implementation of National Pharmacare. The Council recommended that Canada adopt universal, single-payer pharmacare, and set out a plan for how to go about it.

Currently, Canada is an outlier: we have among the highest per capita pharmaceutical spending in the world, and are the only OECD country to have universal health insurance without drug coverage. We know the issues, and we’ve been debating them since the dawn of Canadian medicare. So why hasn’t there been more movement on this file?

The IRPP’s own Colin Busby, who heads up the Faces of Aging research program, joins the podcast to discuss the history of pharmacare in Canada and the hurdles to implementation. For a summary of some of his main points, check out his piece for Policy Options.

Download for free. New episodes every second Wednesday. Tweet your questions and comments to @IRPP or @jbugiel.

Download for free. Tweet your questions and comments to @IRPP.

Colin Busby
Colin Busby is director of policy and outreach at HEC Montréal's Retirement and Savings Institute. He was previously a research director at the Institute for Research on Public Policy. Before joining the IRPP, he was the associate director of research at the C.D. Howe Institute, and has also worked at Industry Canada and the United Nations Industrial Development Organization. LinkedIn and Twitter @cbusby_eco.
More like this
Pharmacare

Related Podcasts